scispace - formally typeset
H

Hiroyuki Mano

Researcher at University of Tokyo

Publications -  308
Citations -  24554

Hiroyuki Mano is an academic researcher from University of Tokyo. The author has contributed to research in topics: Gene & Cancer. The author has an hindex of 66, co-authored 275 publications receiving 22190 citations. Previous affiliations of Hiroyuki Mano include Astellas Pharma & Nagasaki University.

Papers
More filters
Journal ArticleDOI

Molecular pathology quality control in Southeast Asia: Results of a multiregional quality assurance study from MASTER KEY Asia

TL;DR: In this paper , a questionnaire surveying preanalytical procedures (Part I) was administered, quality assessment of immunohistochemistry (IHC) staining and DNA/RNA extracted from the representative FFPE specimens from each hospital (Part II) was conducted, and the quality of DNA and RNA extracted from formalin-fixed paraffinembedded (FFPE) specimens for genomic sequencing (Part III) was examined.
Journal ArticleDOI

Secondary EML4-ALK-positive lung adenocarcinoma in a patient previously treated for acute lymphoblastic leukemia in childhood: a case report.

TL;DR: It was concluded that this echinoderm microtubule-associated protein-like 4 gene-anaplastic lymphoma kinase gene-positive lung adenocarcinoma was a secondary epithelial malignancy.
Journal ArticleDOI

Somatic mutations can induce a noninflamed tumour microenvironment via their original gene functions, despite deriving neoantigens

TL;DR: In this paper , the authors evaluated 88 high-frequency microsatellite instability (MSI-H) colorectal cancers and analyzed the function of the identified neoantigenic mutations and their influence on programmed cell death 1 (PD-1) blockade efficacy.
Patent

Tec tyrosine kinase promoter

TL;DR: In this paper, a DNA having promoter activity of Tec tyrosine kinase and a vector having incorporated within it the promoter to enable a high level expression of an exogenous gene in hematopoietic stem cells and hepatic cells.
Journal ArticleDOI

Identification of Activated RRAS2 in Tongue Carcinoma Cell Line

TL;DR: These findings, which are the first to demonstrate the activating mutation at this codon ofRRAS2, may help to better understand the role of RRAS2 in human carcinogenesis.